Evommune, Inc. (EVMN)
25.61
-0.39
(-1.50%)
USD |
NYSE |
Mar 02, 16:00
26.07
+0.46
(+1.80%)
Pre-Market: 20:00
Evommune Market Cap : 807.33M for March 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 83.60B |
| Moderna, Inc. | 20.87B |
| BillionToOne, Inc. | 3.604B |
| Nektar Therapeutics | 1.183B |
| CorMedix, Inc. | 568.07M |
Market Cap Related Metrics
| PS Ratio | 60.68 |
| PEG Ratio | -0.1681 |
| Price | 25.61 |
| Earnings Yield | -7.17% |
| PEGY Ratio | -0.1681 |